Release Date: 20/09/16 10:46 Summary: Ceasing to be a substantial holder-BRB.AX Price Sensitive: No Download Document 902.23KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%